Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jaber, 2015, Idebenone and neuroprotection: Antioxidant, pro-oxidant, or electron carrier?, J. Bioenerg. Biomembr., 47, 111, 10.1007/s10863-014-9571-y
Attia, 2009, Ameliorating effect of idebenone and/or melatonin against oxidative stress and energy depletion in brain of hypoxic rats, Res. J. Med. Med. Sci., 4, 263
1990, Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: A review, Arch. Gerontol. Geriatr., 11, 177, 10.1016/0167-4943(90)90063-C
2001, Idebenone in patients with cognitive disorders following stroke, Invest. Méd. Int., 28, 14
Yan, 2019, Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson’s Disease Mice, Front. Cell. Neurosci., 12, 529, 10.3389/fncel.2018.00529
Schaffler, 1998, Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug, Arzneimittelforschung, 48, 720
Montenegro, L., Turnaturi, R., Parenti, C., and Pasquinucci, L. (2018). Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy. Nanomaterials, 8.
Thal, 2003, Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease, Neurology, 61, 1498, 10.1212/01.WNL.0000096376.03678.C1
Gillis, 1994, Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders, Drugs Aging, 5, 133, 10.2165/00002512-199405020-00007
2016, Idebenone: A Review in Leber’s Hereditary Optic Neuropathy, Drugs, 76, 805, 10.1007/s40265-016-0574-3
Carelli, 2017, International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy, J. Neuro-Ophthalmol., 37, 371, 10.1097/WNO.0000000000000570
Orssaud, 2019, Raxone in the Leber optical neuropathy: Parisian experience, J. Fr. Ophtalmol., 42, 269, 10.1016/j.jfo.2018.06.010
Baker, 2007, Neurological effects of high-dose idebenone in patients with Friedreich’s ataxia: A randomised, placebo-controlled trial, Lancet Neurol., 6, 878, 10.1016/S1474-4422(07)70220-X
Brandsema, 2010, Intermediate-dose idebenone and quality of life in Friedreich ataxia, Pediatr. Neurol., 42, 338, 10.1016/j.pediatrneurol.2010.01.004
Kearney, 2016, Pharmacological treatments for Friedreich ataxia, Cochrane Database Syst. Rev., 30, CD007791
Cook, 2019, Patient-reported outcomes in Friedreich’s ataxia after withdrawal from idebenone, Acta Neurol. Scand., 139, 533, 10.1111/ane.13088
Lynch, 2010, A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia, Arch. Neurol., 67, 941, 10.1001/archneurol.2010.168
Buyse, 2015, Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): A double-blind randomised placebo-controlled phase 3 trial, Lancet, 385, 1748, 10.1016/S0140-6736(15)60025-3
McDonald, 2016, Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy, Neuromuscul. Disord., 26, 473, 10.1016/j.nmd.2016.05.008
Bodmer, 2009, Pharmacokinetics and metabolism of idebenone in healthy male subjects, Eur. J. Clin. Pharmacol., 65, 493, 10.1007/s00228-008-0596-1
Mistry, 2009, Nanoparticles for direct nose-to-brain delivery of drugs, Int. J. Pharm., 379, 146, 10.1016/j.ijpharm.2009.06.019
Bourganis, 2018, Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics, Eur. J. Pharm. Biopharm., 128, 337, 10.1016/j.ejpb.2018.05.009
Lochhead, 2012, Intranasal delivery of biologics to the central nervous system, Adv. Drug Deliv. Rev., 64, 614, 10.1016/j.addr.2011.11.002
Na, 2010, Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats, Int. J. Pharm., 397, 59, 10.1016/j.ijpharm.2010.06.048
Chavanpatil, 2002, Enhancement of Nasal Absorption of Acyclovir via Cyclodextrins, J. Incl. Phenom. Macrocycl. Chem., 44, 137, 10.1023/A:1023030210154
Brewster, 2007, Cyclodextrins as pharmaceutical solubilizers, Adv. Drug Deliv. Rev., 59, 645, 10.1016/j.addr.2007.05.012
Stancanelli, 2008, Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin, Bioorg. Med. Chem., 16, 8706, 10.1016/j.bmc.2008.07.085
Venuti, 2017, “Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies, J. Mol. Struct., 1146, 512, 10.1016/j.molstruc.2017.06.054
Lopez, 2000, Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone, Int. J. Pharm., 200, 127, 10.1016/S0378-5173(00)00365-3
Crupi, 2013, Phase solubility and FTIR-ATR studies of idebenone/sulfobutylether-β-cyclodextrin inclusion complex, J. Incl. Phenom. Macrocycl. Chem., 75, 255, 10.1007/s10847-012-0110-3
Puglisi, 1996, Preparation and physico-chemical study of inclusion complexes between idebenone and modified β-cyclodextrins, J. Incl. Phenom. Mol. Recognit. Chem., 24, 193, 10.1007/BF01133378
Lauro, 2016, Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain, Pharm. Res., 111, 767, 10.1016/j.phrs.2016.07.043
2014, Cyclodextrins and antioxidants, Crit. Rev. Food Sci. Nutr., 54, 251, 10.1080/10408398.2011.582544
Di Cagno, M.P. (2017). The Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short Overview. Molecules, 22.
Higuchi, 1965, Phase solubility techniques, Adv. Anal. Chem. Instrum., 4, 117
2003, Observing the water molecule in macromolecules and aqueous media using infrared spectrometry, J. Mol. Struct., 648, 27, 10.1016/S0022-2860(02)00493-3
Gans, P., Sabatini, A., and Vacca, A. (2019, July 01). Protonic Software Leeds, UK. Available online: http://www.hyperquad.co.uk/HQ2008.htm.
Gans, 1996, Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs, Talanta, 43, 1739, 10.1016/0039-9140(96)01958-3
Gans, 1999, Determination of equilibrium constants from spectrophometric data obtained from solutions of known pH: The program pHab, Ann. Chim., 89, 45
Shrivastava, 2011, Methods for the determination of limit of detection and limit of quantitation of the analytical methods, Chron. Young Sci., 2, 21, 10.4103/2229-5186.79345
Zhang, 2017, Experimental and molecular docking investigations on the inclusion mechanism of the complex of phloridzin and hydroxypropyl-beta-cyclodextrin, Food Chem., 215, 124, 10.1016/j.foodchem.2016.07.155
Krieger, 2014, YASARA View-molecular graphics for all devices-from smartphones to workstations, Bioinformatics, 30, 2981, 10.1093/bioinformatics/btu426
Land, 2018, YASARA: A Tool to Obtain Structural Guidance in Biocatalytic Investigations, Methods Mol. Biol., 1685, 43, 10.1007/978-1-4939-7366-8_4
Duan, 2003, A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations, J. Comput. Chem., 24, 1999, 10.1002/jcc.10349
Jakalian, 2002, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comput. Chem., 23, 1623, 10.1002/jcc.10128
Wongpituk, 2017, Structural dynamics and binding free energy of neral-cyclodextrins inclusion complexes: Molecular dynamics simulation, Mol. Simul., 43, 1356, 10.1080/08927022.2017.1356458
Genheden, 2015, The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities, Expert Opin. Drug Discov., 10, 449, 10.1517/17460441.2015.1032936
Cosco, 2016, Rutin-loaded chitosan microspheres: Characterization and evaluation of the anti-inflammatory activity, Carbohydr. Polym., 152, 583, 10.1016/j.carbpol.2016.06.039
Paolino, 2013, Gemcitabine-loaded biocompatible nano capsules for the effective treatment of human cancer, Nanomedicine (Lond), 8, 193, 10.2217/nnm.12.101
Rajamohan, 2008, Spectrofluorimetricstudy on inclusion complexation of 2-amino-6-fluorobenzothiazole with β-cyclodextrin, Collect. Czechoslov. Chem. Commun., 73, 147, 10.1135/cccc20080147
Crupi, 2007, UV–vis and FTIR–ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrins, J. Pharm. Biomed. Anal., 44, 110, 10.1016/j.jpba.2007.01.054
Brubach, 2001, Dependence of water dynamics upon confinement size, J. Phys. Chem. B, 105, 430, 10.1021/jp002983s
Crupi, 2014, Direct evidence of gel-sol transition in cyclodextrin-based hydrogels as revealed by FTIR-ATR spectroscopy, Soft Matter, 10, 2320, 10.1039/C3SM52354C
Gavira, 2003, Dehydration of β-cyclodextrin: An IR ν(OH) band profile analysis, Vib. Spectrosc., 32, 137, 10.1016/S0924-2031(03)00029-8
Venuti, 2016, Solute-solvent interactions in aqueous solutions of sulfobutyl ether-β-cyclodextrin as probed by UV-Raman and FTIR-ATR analysis, J. Phys. Chem. B, 120, 3746, 10.1021/acs.jpcb.6b02261
Crupi, 2007, Raman spectroscopy: Probing dynamics of water molecules confined in nanoporous silica glasses, Eur. Phys. J. Spec. Top., 141, 61, 10.1140/epjst/e2007-00018-x
Bratu, 2004, Infrared spectroscopic study of triacetyl-β-cyclodextrin and its inclusion complex with nicapiridine, Spectroscopy, 18, 459, 10.1155/2004/727869
Castiglione, 2012, Effect of cross-linking properties on the vibrational dynamics of cyclodextrins-based polymers: An experimental–numerical study, J. Phys. Chem. B, 116, 7952, 10.1021/jp303006a
Stancanelli, 2015, Isoflavone aglycons-sulfobutyl ether-β-cyclodextrin inclusion complexes: In solution and solid state studies, J. Incl. Phenom. Macrocycl. Chem., 83, 27, 10.1007/s10847-015-0535-6
Crupi, 2000, Anharmonic effects and vibrational dynamics in h-bonded liquids by attenuated total reflectance FT-IR spectroscopy, J. Phys. Chem. A, 104, 3933, 10.1021/jp993900e
Gallina, 2006, Vibrational analysis of molecular interactions in aqueous glucose solutions. Temperature and concentration effects, J. Phys. Chem. B, 110, 8856, 10.1021/jp056213y
Celia, 2007, Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate, Int. J. Pharm., 534, 316, 10.1016/j.ijpharm.2017.10.014
Crupi, 2013, Modelling the interplay between covalent and physical interactions in cyclodextrin-based hydrogel: Effect of water confinement, Soft Matter, 9, 6457, 10.1039/c3sm50827g
Jug, 2005, Influence of cyclodextrin complexation on piroxicam gel formulations, Acta Pharm., 55, 223
Mohan, 2012, Water soluble complexes of curcumin with cyclodextrins: Characterization by FT-Raman spectroscopy, Vib. Spectrosc., 62, 77, 10.1016/j.vibspec.2012.05.002
Sancho, 2016, Theoretical and experimental study of inclusion complexes of β-cyclodextrins with chalcone and 2′,4′-dihydroxychalcone, J. Phys. Chem. B, 120, 3000, 10.1021/acs.jpcb.5b11317
Hibberta, 2016, The death of the job plot, transparency, open science and online tools, uncertainty estimation methods and other developments in supramolecular chemistry data analysis, Chem. Commun., 52, 12792, 10.1039/C6CC03888C
Ulatowski, 2016, Recognizing the limited applicability of job plots in studying host-guest interactions in supramolecular chemistry, J. Org. Chem., 81, 1746, 10.1021/acs.joc.5b02909
Floresta, 2019, Metyrapone-β-cyclodextrin supramolecular interactions inferred by complementary spectroscopic/spectrometric and computational studies, J. Mol. Struct., 1176, 815, 10.1016/j.molstruc.2018.09.018
Damiani, 2019, Repurposing of Idebenone as a potential anticancer agent, Biochem. J., 476, 245, 10.1042/BCJ20180384
Tai, 2011, Idebenone Induces Apoptotic Cell Death in the Human Dopaminergic Neuroblastoma SHSY-5Y Cells, Neurotox. Res., 20, 321, 10.1007/s12640-011-9245-z
Loftsson, 2005, Cyclodextrins in drug delivery, Expert Opin. Drug Deliv., 2, 335, 10.1517/17425247.2.1.335
Costa, 2015, Cyclodextrins enhance the antioxidant activity of essential oils fromthree Lamiaceae species, Ind. Crop. Prod., 70, 341, 10.1016/j.indcrop.2015.03.065
Kim, H., Yiluo, H., Park, S., Lee, J.Y., Cho, E., and Jung, S. (2016). Characterization and Enhanced Antioxidant Activity of the Cysteinyl β-Cyclodextrin-Baicalein Inclusion Complex. Molecules, 21.
2005, Complexation of Apple Antioxidants: Chlorogenic Acid, Quercetin and Rutin by β-Cyclodextrin (β-CD), J. Incl. Phenom. Macrocycl. Chem., 53, 121, 10.1007/s10847-005-1620-z
Roy, 2018, β-cyclodextrin encapsulated polyphenols as effective antioxidants, Biopolymers, 109, e23084, 10.1002/bip.23084
Li, S., Yuan, L., Chen, Y., Zhou, W., and Wang, X. (2017). Studies on the Inclusion Complexes of Daidzein with β-Cyclodextrin and Derivatives. Molecules, 22.
Chouhan, 2014, Hydroxypropyl-β-cyclodextrin: A Novel Transungual Permeation Enhancer for Development of Topical Drug Delivery System for Onychomycosis, J. Drug Deliv., 2014, 950358, 10.1155/2014/950358
Jansook, 2018, Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications, Int. J. Pharm., 535, 272, 10.1016/j.ijpharm.2017.11.018
Coisne, C., Tilloy, S., Monflier, E., Wils, D., Fenart, L., and Gosselet, F. (2016). Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases. Molecules, 21.
Zimmer, 2016, Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming, Sci. Transl. Med., 8, 333ra50, 10.1126/scitranslmed.aad6100
Kim, 2009, Pharmacokinetic evaluation and modeling of formulated levodopa intranasal delivery systems, Eur. J. Pharm. Sci., 38, 525, 10.1016/j.ejps.2009.09.019
Rathi, 2011, Effect of permeation enhancers on permeation kinetics of idebenone through the bovine buccal mucosa, Indian J. Pharm. Educ. Res., 45, 370
Ventura, 2001, Biomembrane model interaction and percutaneous absorption of papaverine through rat skin: Effects of cyclodextrins as penetration enhancers, J. Drug Target., 9, 379, 10.3109/10611860108998773